332 related articles for article (PubMed ID: 23153282)
1. Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
J Med Chem; 2012 Dec; 55(23):10424-36. PubMed ID: 23153282
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase A and B inhibiting effect and molecular modeling of some synthesized coumarin derivatives.
Abdelhafez OM; Amin KM; Ali HI; Abdalla MM; Batran RZ
Neurochem Int; 2013 Jan; 62(2):198-209. PubMed ID: 23182697
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
5. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Quezada E; Picciau C; Delogu G; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Jun; 19(12):3268-70. PubMed ID: 19423346
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
8. Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors.
Shi L; Yang Y; Li ZL; Zhu ZW; Liu CH; Zhu HL
Bioorg Med Chem; 2010 Feb; 18(4):1659-64. PubMed ID: 20117937
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
11. 8-Substituted 3-arylcoumarins as potent and selective MAO-B inhibitors: synthesis, pharmacological evaluation, and docking studies.
Viña D; Matos MJ; Ferino G; Cadoni E; Laguna R; Borges F; Uriarte E; Santana L
ChemMedChem; 2012 Mar; 7(3):464-70. PubMed ID: 22287164
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins.
Chimenti F; Secci D; Bolasco A; Chimenti P; Bizzarri B; Granese A; Carradori S; Yáñez M; Orallo F; Ortuso F; Alcaro S
J Med Chem; 2009 Apr; 52(7):1935-42. PubMed ID: 19267475
[TBL] [Abstract][Full Text] [Related]
13. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Janeiro P; Borges F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2010 Sep; 20(17):5157-60. PubMed ID: 20659799
[TBL] [Abstract][Full Text] [Related]
14. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety.
Ke S; Li Z; Qian X
Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501
[TBL] [Abstract][Full Text] [Related]
15. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
17. Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies.
Carotti A; Carrieri A; Chimichi S; Boccalini M; Cosimelli B; Gnerre C; Carotti A; Carrupt PA; Testa B
Bioorg Med Chem Lett; 2002 Dec; 12(24):3551-5. PubMed ID: 12443774
[TBL] [Abstract][Full Text] [Related]
18. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
[TBL] [Abstract][Full Text] [Related]
20. 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors.
Lühr S; Vilches-Herrera M; Fierro A; Ramsay RR; Edmondson DE; Reyes-Parada M; Cassels BK; Iturriaga-Vásquez P
Bioorg Med Chem; 2010 Feb; 18(4):1388-95. PubMed ID: 20123154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
